Search research articles
Contact Us
Filters
Showing results (91-100 of 198) with videos related to
Page
of 20
Sort By:
Journal of Clinical Lipidology
|
January 15, 2013
New-onset extremely low levels of high-density lipoprotein cholesterol
Aris P Agouridis, Evangelos N Liberopoulos, Michael S Kostapanos, et al.
Current Pharmaceutical Design
|
November 10, 2015
All for Statins and Statins for All; An Update
Aris P Agouridis, Moses S Elisaf, Devaki R Nair, et al.
The Annals of Pharmacotherapy
|
June 28, 2002
SIADH and hyponatremia with theophylline
Evagelos N Liberopoulos, George H Alexandridis, Dimitris S Christidis, et al.
World Journal of Diabetes
|
February 26, 2014
Rationale, design and baseline patient characteristics of the optimal type 2 diabetes management including benchmarking and standard treatment study in Greece
Michael S Kostapanos, Vasilis Tsimihodimos, Moses S Elisaf, et al.
Current Vascular Pharmacology
|
October 16, 2008
The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview
Eleni S Nakou, Evangelos N Liberopoulos, Haralampos J Milionis, et al.
Therapeutic Advances in Endocrinology and Metabolism
|
October 8, 2015
Effects of benchmarking on the quality of type 2 diabetes care: results of the OPTIMISE (Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment) study in Greece
Vasilis Tsimihodimos, Michael S Kostapanos, Alexandros Moulis, et al.
Archives of Medical Science : AMS
|
January 21, 2016
Ear lobe crease: a marker of coronary artery disease?
Aris P Agouridis, Moses S Elisaf, Devaki R Nair, et al.
Current Vascular Pharmacology
|
May 29, 2010
Do statins beneficially or adversely affect glucose homeostasis?
Michael S Kostapanos, George L Liamis, Haralampos J Milionis, et al.
Fundamental & Clinical Pharmacology
|
August 14, 2003
Lipid-lowering drugs and serum liver enzymes: the effects of body weight and baseline enzyme levels
Dimitrios N Kiortsis, Spyridon Nikas, Katerina Hatzidimou, et al.
The Review of Diabetic Studies : RDS
|
January 1, 2014
Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?
Aris P Agouridis, Christos V Rizos, Moses S Elisaf, et al.
Page
of 20
Search research articles
Search
Showing results (91-100 of 198) with videos related to
Sort By:
Page
of 20
Journal of Clinical Lipidology
|
January 15, 2013
New-onset extremely low levels of high-density lipoprotein cholesterol
Aris P Agouridis, Evangelos N Liberopoulos, Michael S Kostapanos, et al.
Current Pharmaceutical Design
|
November 10, 2015
All for Statins and Statins for All; An Update
Aris P Agouridis, Moses S Elisaf, Devaki R Nair, et al.
The Annals of Pharmacotherapy
|
June 28, 2002
SIADH and hyponatremia with theophylline
Evagelos N Liberopoulos, George H Alexandridis, Dimitris S Christidis, et al.
World Journal of Diabetes
|
February 26, 2014
Rationale, design and baseline patient characteristics of the optimal type 2 diabetes management including benchmarking and standard treatment study in Greece
Michael S Kostapanos, Vasilis Tsimihodimos, Moses S Elisaf, et al.
Current Vascular Pharmacology
|
October 16, 2008
The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview
Eleni S Nakou, Evangelos N Liberopoulos, Haralampos J Milionis, et al.
Therapeutic Advances in Endocrinology and Metabolism
|
October 8, 2015
Effects of benchmarking on the quality of type 2 diabetes care: results of the OPTIMISE (Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment) study in Greece
Vasilis Tsimihodimos, Michael S Kostapanos, Alexandros Moulis, et al.
Archives of Medical Science : AMS
|
January 21, 2016
Ear lobe crease: a marker of coronary artery disease?
Aris P Agouridis, Moses S Elisaf, Devaki R Nair, et al.
Current Vascular Pharmacology
|
May 29, 2010
Do statins beneficially or adversely affect glucose homeostasis?
Michael S Kostapanos, George L Liamis, Haralampos J Milionis, et al.
Fundamental & Clinical Pharmacology
|
August 14, 2003
Lipid-lowering drugs and serum liver enzymes: the effects of body weight and baseline enzyme levels
Dimitrios N Kiortsis, Spyridon Nikas, Katerina Hatzidimou, et al.
The Review of Diabetic Studies : RDS
|
January 1, 2014
Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?
Aris P Agouridis, Christos V Rizos, Moses S Elisaf, et al.
Page
of 20